Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Smoking and Ventricular Repolarization

NCT03916341 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT03916341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03916341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Smoking and Ventricular Repolarization
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2019
Completion date
April 10, 2023
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prolonged qtc interval, sudden cardiac death